The search for new antimicrobials: why we need new options (Q36322113)

13 August 2017

1 reference

title

The search for new antimicrobials: why we need new options (English)

1 reference

13 August 2017

Stephen H Zinner

1

1 reference

13 August 2017

publication date

1 December 2005

1 reference

Expert Review of Anti-infective Therapy

13 August 2017

published in

1 reference

13 August 2017

volume

3

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

907-913

1 reference

Impact of travel on international spread of antimicrobial resistance

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Transfer of vancomycin-resistant enterococci via health care worker hands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

The changing epidemiology of Staphylococcus aureus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Prevalence of antibiotic resistance in anaerobic bacteria: worrisome developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Macrolide resistance: an increasing concern for treatment failure in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Widespread use of fluoroquinolones versus emerging resistance in pneumococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Methicillin-resistant staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Methicillin-resistant Staphylococcus aureus disease in three communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

A clone of methicillin-resistant Staphylococcus aureus among professional football players.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Increased antibiotic resistance in respiratory tract pathogens: PROTEKT US--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Quinolone resistance among pneumococci: therapeutic and diagnostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Pneumococcal resistance to macrolides, lincosamides, ketolides, and streptogramin B agents: molecular mechanisms and resistance phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Bacteroides, Prevotella, and Porphyromonas species: a review of antibiotic resistance and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Emergence of fluoroquinolone resistance among Bacteroides species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Grou

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Incidence and outcome of polymicrobial ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Newer treatment options for skin and soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

The glycylcyclines: a comparative review with the tetracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Trends in antimicrobial drug development: implications for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Dalbavancin: an investigational glycopeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Oritavancin: a new avenue for resistant Gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

The relentless rise of resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Medical Treatment of Diabetic Foot Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐Resistant Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.907

21 January 2018

Identifiers

DOI

10.1586/14787210.3.6.907

1 reference

13 August 2017

1 reference